Source - RNS
RNS Number : 2527L
Accrol Group Holdings PLC
29 September 2016
 

This announcement contains inside information

 

Accrol Group Holdings plc (the "Company" or "Accrol")

 

Director's Dealing

 

Accrol Group Holdings plc, the AIM listed leading independent tissue converter, is pleased to announce that is has been notified that Stephen Crossley, CEO of Accrol, has purchased 100,000 ordinary shares of £0.001 each ("Ordinary Shares") via his SIPP on 29th September 2016 at a price of 132p per Ordinary Share.

Following this transaction, Stephen has an interest in 100,000 Ordinary Shares, representing approximately 0.1 per cent. of the Company's issued Ordinary Share capital.

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 


Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Stephen Crossley

2

Reason for the notification

a)

Position/status

CEO

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Accrol Group Holdings plc

b)

LEI

(Pending)

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.001

 

ISIN: GB00BZ6VT592

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

132p

100,000

d)

Aggregated information

- Aggregated volume

- Price


N/A - single transaction

e)

Date of the transaction

29th September 2016

f)

Place of the transaction

London Stock Exchange, AIM

 

For further information please contact:


Zeus Capital Limited (Nominated Adviser & Broker) 


Dan Bate / Jonathan Sharp        

Tel: +44 (0) 161 831 1512

Dominic King / Adam Pollock / Mike Seabrook

Tel: +44 (0) 20 3829 5000

Camarco (Media enquiries) 


Jennifer Renwick / Billy Clegg                                 

Tel: +44 (0) 203 757 4994

Notes to Editors

 

Accrol manufactures toilet rolls, kitchen rolls and facial tissues as well as other tissue products at the Company's 350,000 sq. ft. manufacturing, storage and distribution facility in Blackburn, Lancashire. Accrol currently manufactures approximately 16 million units per week and supplies some of the UK's largest retailers, providing both Accrol branded and Private Label products.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHBUGDCGXDBGLC

Related Charts

Accrol Group Hldgs (ACRL)

-1.25 (-0.99%)
delayed 18:15PM